Solitary Fibrous Tumor: A retrospective analysis of clinicopathological characteristics and palliative treatment of 67 cases
Authors:
- Merve AkbulutMAMerve Akbulut
- Sven-Thorsten LiffersSLSven-Thorsten Liffers
- Ilektra A. MavroeidiIMIlektra A. Mavroeidi
- Johanna FalkenhorstJFJohanna Falkenhorst
- Wiebke K. GuderWGWiebke K. Guder
- Dimosthenis AndreouDADimosthenis Andreou
- Moritz KathsMKMoritz Kaths
- Roemer van WijkRWRoemer van Wijk
- Christoph PöttgenCPChristoph Pöttgen
- Sebastian BauerSBSebastian Bauer
- Rainer HamacherRHRainer Hamacher
Open Access
- 10 June 2025
- journal article
- Published by Elsevier in ESMO Rare Cancers
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆Annals of Oncology, 2021
- Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trialThe Lancet Oncology, 2020
- Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trialThe Lancet Oncology, 2019
- Comparison and evaluation of risk factors for meningeal, pleural, and extrapleural solitary fibrous tumors: A clinicopathological study of 92 cases confirmed by STAT6 immunohistochemical stainingPathology - Research and Practice, 2017
- Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma GroupEuropean Journal of Cancer, 2015
- Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumourEuropean Journal of Cancer, 2014
- Response to chemotherapy of solitary fibrous tumour: A retrospective studyEuropean Journal of Cancer, 2013
- Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment modelLaboratory Investigation, 2012
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumorCancer, 2011
- Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitorsBritish Journal of Cancer, 2009